Taichu Biotechnology Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Series A1
- Investors
-
17
Taichu Biotechnology General Information
Description
Operator and developer of a biopharmaceutical company intended to become a CRO+CDMO technology platform for the whole industry chain. The company's business focus is from drug non-clinical research to CDMO, its services include non-clinical drugability evaluation (CRO) of biomedicine, antibody drug development and production (CRO/CDMO), research and development of chemical preparations, and CDMO services, providing tailor-made CRO+CDMO technical services for single and combined business segments for the R&D and production of various new drugs.
Contact Information
Website
taichubio.comCorporate Office
- Building 6, No. 308, Pingda Road, Lingang New Area
- Fengxian District
- Shanghai, 200000
- China
Corporate Office
- Building 6, No. 308, Pingda Road, Lingang New Area
- Fengxian District
- Shanghai, 200000
- China
Taichu Biotechnology Timeline
Taichu Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A1) | 08-Mar-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 08-May-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 15-Aug-2022 | $44.7M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 18-Jul-2022 | $44.7M | $44.7M | Completed | Generating Revenue |
Taichu Biotechnology Comparisons
Industry
Financing
Details
Taichu Biotechnology Competitors (2)
One of Taichu Biotechnology’s 2 competitors is Shanghai Medicilon, a Formerly VC-backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shanghai Medicilon | Formerly VC-backed | Shanghai, China | ||||
| ChemPartner | Formerly PE-Backed | Shanghai, China |
Taichu Biotechnology Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fortera Capital | PE/Buyout | Minority | ||
| Hangzhou Tailong Venture Capital Partnership | Growth/Expansion | Minority | ||
| Shanghai Guanyu Investment Development | Growth/Expansion | Minority | ||
| TigerYeah Capital | Venture Capital | Minority | ||
| Ao Peng Investment | PE/Buyout | Minority |
Taichu Biotechnology Acquisitions (1)
Taichu Biotechnology’s most recent deal was a Merger/Acquisition with Taijin Biotechnology. The deal was made on 27-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Taijin Biotechnology | 27-Jan-2022 | Merger/Acquisition | Biotechnology |
Taichu Biotechnology Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Taijin Biotechnology | Shanghai, China | 2021 |
Taichu Biotechnology FAQs
-
When was Taichu Biotechnology founded?
Taichu Biotechnology was founded in 2020.
-
Where is Taichu Biotechnology headquartered?
Taichu Biotechnology is headquartered in Shanghai, China.
-
What industry is Taichu Biotechnology in?
Taichu Biotechnology’s primary industry is Biotechnology.
-
Is Taichu Biotechnology a private or public company?
Taichu Biotechnology is a Private company.
-
What is Taichu Biotechnology’s current revenue?
The current revenue for Taichu Biotechnology is .
-
How much funding has Taichu Biotechnology raised over time?
Taichu Biotechnology has raised $103M.
-
Who are Taichu Biotechnology’s investors?
Fortera Capital, Hangzhou Tailong Venture Capital Partnership, Shanghai Guanyu Investment Development, TigerYeah Capital, and Ao Peng Investment are 5 of 17 investors who have invested in Taichu Biotechnology.
-
Who are Taichu Biotechnology’s competitors?
Shanghai Medicilon and ChemPartner are competitors of Taichu Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process